Advances in the treatment of urinary tract infection.
Single dose treatment regimens are currently the treatment of choice in women with acute urethrocystitis. Women who have concomitant asymptomatic renal infections will have a recurrence and require further investigation and more conventional 14-day treatment regimens. Single dose treatment is a specific and moderately sensitive diagnostic aid for women with urinary infection. Further carefully planned studies are required to determine optimal treatment regimens for women with renal infection and men with infections originating in the kidneys or prostate.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011472:Prostatitis / Q000188:drug therapy; D011704:Pyelonephritis / Q000175:diagnosis / Q000188:drug therapy; D012008:Recurrence; D014546:Urinary Catheterization / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents